Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Adrenocortical carcinoma risk factors
Introduction
Overview
Overview
The most important risk factors for developing adrenocortical cancer are Lynch syndrome, Beckwith-Wiedemann syndrome, Carney complex, Neurofibromatosis type 1, Multiple endocrine neoplasia type 1 (MEN1), and Carney complex.
Risk Factors
Risk Factors
Risk factors associated with adrenocortical carcinoma are:
- Lynch syndrome[1]
- Beckwith-Wiedemann syndrome (BWS)[2]
- Carney complex[3]
- Neurofibromatosis type 1 [4]
- Multiple endocrine neoplasia type 1(MEN1)[5]
| Differential Diagnosis | Gene mutations | Clinical picture |
|---|---|---|
| Lynch syndrome[1] | ||
| Neurofibromatosis type 1 [4] |
| |
| MEN1[5] |
|
|
| Carney complex[3] | ||
| BWS[2] |
References
References
- ↑ 1.0 1.1 Carethers JM, Stoffel EM (2015). “Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer”. World J Gastroenterol. 21 (31): 9253–61. doi:10.3748/wjg.v21.i31.9253. PMC 4541378. PMID 26309352.
- ↑ 2.0 2.1 H. Segers, R. Kersseboom, M. Alders, R. Pieters, A. Wagner & M. M. van den Heuvel-Eibrink (2012). “Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients”. European journal of cancer (Oxford, England : 1990). 48 (17): 3249–3256. doi:10.1016/j.ejca.2012.06.008. PMID 22796116. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 Correa R, Salpea P, Stratakis CA (2015). “Carney complex: an update”. Eur J Endocrinol. 173 (4): M85–97. doi:10.1530/EJE-15-0209. PMC 4553126. PMID 26130139.
- ↑ 4.0 4.1 Hirbe AC, Gutmann DH (2014). “Neurofibromatosis type 1: a multidisciplinary approach to care”. Lancet Neurol. 13 (8): 834–43. doi:10.1016/S1474-4422(14)70063-8. PMID 25030515.
- ↑ 5.0 5.1 B. Gatta-Cherifi, O. Chabre, A. Murat, P. Niccoli, C. Cardot-Bauters, V. Rohmer, J. Young, B. Delemer, H. Du Boullay, M. F. Verger, J. M. Kuhn, J. L. Sadoul, Ph Ruszniewski, A. Beckers, M. Monsaingeon, E. Baudin, P. Goudet & A. Tabarin (2012). “Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’etude des Tumeurs Endocrines database”. European journal of endocrinology. 166 (2): 269–279. doi:10.1530/EJE-11-0679. PMID 22084155. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]